The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Brackman, Gilles ^a   Breyne, Koen ^a   De Rycke, Riet ^a,b   Vermote, Arno ^a   Van Nieuwerburgh, Filip ^a   Meyer, Evelyne ^a   Van Calenbergh, Serge ^a   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; GALLIC ACID; HAMAMELITANNIN; HEXOSE; PEPTIDOGLYCAN; VIRULENCE FACTOR;

ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; BIOFILM; BIOSYNTHESIS; CELL WALL; DRUG EFFECTS; EXTRACELLULAR SPACE; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MUTATION; PHYSIOLOGY; QUORUM SENSING; STAPHYLOCOCCUS AUREUS; VIRULENCE;

ANTI-BACTERIAL AGENTS; BIOFILMS; CELL WALL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EXTRACELLULAR SPACE; GALLIC ACID; HEXOSES; MICROBIAL SENSITIVITY TESTS; MUTATION; PEPTIDOGLYCAN; QUORUM SENSING; STAPHYLOCOCCUS AUREUS; VIRULENCE; VIRULENCE FACTORS;

EID: 84957593042     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20321     Document Type: Article

References (56)

1. Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L. & Fowler, V. G., Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical microbiology reviews 28, 603-661, doi: 10.1128/cmr.00134-14 (2015).
2. Stryjewski, M. E. & Corey, G. R. Methicillin-resistant Staphylococcus aureus: An evolving pathogen. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America 58 Suppl 1, S10-19, doi: 10.1093/cid/cit613 (2014).
3. Knox, J., Uhlemann, A. C. & Lowy, F. D. Staphylococcus aureus infections: Transmission within households and the community. Trends in microbiology 23, 437-444, doi: 10.1016/j.tim.2015.03.007 (2015).
4. Gotz, F. Staphylococcus and biofilms. Molecular microbiology 43, 1367-1378 (2002).
5. Fux, C. A., Costerton, J. W., Stewart, P. S. & Stoodley, P. Survival strategies of infectious biofilms. Trends in microbiology 13, 34-40, doi: 10.1016/j.tim.2004.11.010 (2005).
6. McCarthy, H. et al. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Frontiers in cellular and infection microbiology 5, 1, doi: 10.3389/fcimb.2015.00001 (2015).
7. Kiedrowski, M. R. & Horswill, A. R. New approaches for treating staphylococcal biofilm infections. Annals of the New York Academy of Sciences 1241, 104-121, doi: 10.1111/j.1749-6632.2011.06281.x (2011).
8. Conlon, B. P. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. Aureus disease. BioEssays: news and reviews in molecular, cellular and developmental biology 36, 991-996, doi: 10.1002/bies.201400080 (2014).
9. Roca, I. et al. The global threat of antimicrobial resistance: science for intervention. New microbes and new infections 6, 22-29, doi: 10.1016/j.nmni.2015.02.007 (2015).
10. Waters, C. M. & Bassler, B. L. Quorum sensing: cell-To-cell communication in bacteria. Annual review of cell and developmental biology 21, 319-346, doi: 10.1146/annurev.cellbio.21.012704.131001 (2005).
11. Brackman, G. & Coenye, T. Inhibition of Quorum Sensing in Staphylococcus spp. Current pharmaceutical design 21, 2101-2108 (2015).
12. Rezzonico, F. & Duffy, B. Lack of genomic evidence of AI-2 receptors suggests a non-quorum sensing role for luxS in most bacteria. BMC microbiology 8, 154, doi: 10.1186/1471-2180-8-154 (2008).
13. Doherty, N., Holden, M. T., Qazi, S. N., Williams, P. & Winzer, K. Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing. Journal of bacteriology 188, 2885-2897, doi: 10.1128/jb.188.8.2885-2897.2006 (2006).
14. Singh, R. & Ray, P. Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Future microbiology 9, 669-681, doi: 10.2217/fmb.14.31 (2014).
15. Mellbye, B. & Schuster, M. The sociomicrobiology of antivirulence drug resistance: A proof of concept. mBio 2, doi: 10.1128/mBio.00131-11 (2011).
16. Kiran, M. D. et al. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Molecular pharmacology 73, 1578-1586, doi: 10.1124/mol.107.044164 (2008).
17. Brackman, G., Cos, P., Maes, L., Nelis, H. J. & Coenye, T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrobial agents and chemotherapy 55, 2655-2661, doi: 10.1128/aac.00045-11 (2011).
18. Novick, R. P. & Geisinger, E. Quorum sensing in staphylococci. Annual review of genetics 42, 541-564, doi: 10.1146/annurev. genet.42.110807.091640 (2008).
19. Muthaiyan, A., Silverman, J. A., Jayaswal, R. K. & Wilkinson, B. J. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrobial agents and chemotherapy 52, 980-990, doi: 10.1128/aac.01121-07 (2008).
20. Maki, H., McCallum, N., Bischoff, M., Wada, A. & Berger-Bachi, B.TcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrobial agents and chemotherapy 48, 1953-1959, doi: 10.1128/aac.48.6.1953-1959.2004 (2004).
21. Kuroda, M. et al. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Molecular microbiology 49, 807-821 (2003).
22. McAleese, F. et al. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. Aureus-Type resistance to vancomycin. Journal of bacteriology 188, 1120-1133, doi: 10.1128/jb.188.3.1120-1133.2006 (2006).
23. Mongodin, E. et al. Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin. Journal of bacteriology 185, 4638-4643 (2003).
24. Scherl, A. et al. Exploring glycopeptide-resistance in Staphylococcus aureus: A combined proteomics and transcriptomics approach for the identification of resistance-related markers. BMC genomics 7, 296, doi: 10.1186/1471-2164-7-296 (2006).
25. Rose, W. E., Fallon, M., Moran, J. J. & Vanderloo, J. P. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression. Antimicrobial agents and chemotherapy 56, 4422-4427, doi: 10.1128/aac.00676-12 (2012).
26. Hiramatsu, K. Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance. The Lancet. Infectious diseases 1, 147-155, doi: 10.1016/s1473-3099(01)00091-3 (2001).
27. Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H. & Hiramatsu, K. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrobial agents and chemotherapy 44, 2276-2285 (2000).
28. Reed, P. et al. Staphylococcus aureus Survives with a Minimal Peptidoglycan Synthesis Machine but Sacrifices Virulence and Antibiotic Resistance. Plos pathogens 11, e1004891, doi: 10.1371/journal.ppat.1004891 (2015).
29. Mann, E. E. et al. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PloS one 4, e5822, doi: 10.1371/journal.pone.0005822 (2009).
30. Pichereau, S. et al. Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-Associated methicillin-resistant Staphylococcus aureus strain MW2. Antimicrobial agents and chemotherapy 56, 140-147, doi: 10.1128/aac.05113-11 (2012).
31. Stevens, D. L. et al. Impact of antibiotics on expression of virulence-Associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. The Journal of infectious diseases 195, 202-211, doi: 10.1086/510396 (2007).
32. Joo, H. S., Chan, J. L., Cheung, G. Y. & Otto, M. Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-Associated methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 54, 4942-4944, doi: 10.1128/aac.00064-10 (2010).
33. Demon, D. et al. The intramammary efficacy of first generation cephalosporins against Staphylococcus aureus mastitis in mice. Veterinary microbiology 160, 141-150, doi: 10.1016/j.vetmic.2012.05.017 (2012).
34. Cobrado, L. et al. Cerium, chitosan and hamamelitannin as novel biofilm inhibitors? J Antimicrob Chemother 67, 1159-1162, doi: 10.1093/jac/dks007 (2012).
35. Cobrado, L., Silva-Dias, A., Azevedo, M. M., Pina-Vaz, C. & Rodrigues, A. G. In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections. J Antimicrob Chemother 68, 126-130, doi: 10.1093/jac/dks376 (2013).
36. Kiran, M. D., Giacometti, A., Cirioni, O. & Balaban, N. Suppression of biofilm related, device-Associated infections by staphylococcal quorum sensing inhibitors. Int J Artif Organs 31, 761-770 (2008).
37. Sully, E. K. et al. Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. Plos pathogens 10, e1004174, doi: 10.1371/journal.ppat.1004174 (2014).
38. Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C. & Mattick, J. S. Extracellular DNA required for bacterial biofilm formation. Science (New York, N.Y.) 295, 1487, doi: 10.1126/science.295.5559.1487 (2002).
39. Flemming, H. C. & Wingender, J. The biofilm matrix. Nature reviews. Microbiology 8, 623-633, doi: 10.1038/nrmicro2415 (2010).
40. Fischer, A. et al. GdpS contributes to Staphylococcus aureus biofilm formation by regulation of eDNA release. International journal of medical microbiology : Ijmm 304, 284-299, doi: 10.1016/j.ijmm.2013.10.010 (2014).
41. Doroshenko, N. et al. Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin. Antimicrobial agents and chemotherapy 58, 7273-7282, doi: 10.1128/aac.03132-14 (2014).
42. Gaupp, R. et al. Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype. Antimicrobial agents and chemotherapy 59, 4226-4238, doi: 10.1128/aac.00160-15 (2015).
43. Okshevsky, M., Regina, V. R. & Meyer, R. L. Extracellular DNA as a target for biofilm control. Current opinion in biotechnology 33, 73-80, doi: 10.1016/j.copbio.2014.12.002 (2015).
44. Piepers, S. et al. Prevalence and distribution of mastitis pathogens in subclinically infected dairy cows in Flanders, Belgium. The Journal of dairy research 74, 478-483, doi: 10.1017/s0022029907002841 (2007).
45. Tenhagen, B. A., Hansen, I., Reinecke, A. & Heuwieser, W. Prevalence of pathogens in milk samples of dairy cows with clinical mastitis and in heifers at first parturition. The Journal of dairy research 76, 179-187, doi: 10.1017/s0022029908003786 (2009).
46. Vandecandelaere, I., Depuydt, P., Nelis, H. J. & Coenye, T. Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms. Pathogens and disease 70, 321-331, doi: 10.1111/2049-632x.12133 (2014).
47. Tsang, L. H., Daily, S. T., Weiss, E. C. & Smeltzer, M. S. Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation. Infect Immun 75, 4528-4533, doi: 10.1128/iai.00603-07 (2007).
48. Sopirala, M. M. et al. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy 54, 4678-4683, doi: 10.1128/aac.00497-10 (2010).
49. Peeters, E., Nelis, H. J. & Coenye, T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. Journal of microbiological methods 72, 157-165, doi: 10.1016/j.mimet.2007.11.010 (2008).
50. Kuroda, M. et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (London, England) 357, 1225-1240 (2001).
51. Baggerly, K. A., Deng, L., Morris, J. S. & Aldaz, C. M. Differential expression in SAGE: Accounting for normal between-library variation. Bioinformatics (Oxford, England) 19, 1477-1483 (2003).
52. Attia, A. S., Benson, M. A., Stauff, D. L., Torres, V. J. & Skaar, E. P. Membrane damage elicits an immunomodulatory program in Staphylococcus aureus. Plos pathogens 6, e1000802, doi: 10.1371/journal.ppat.1000802 (2010).
53. Osorio, F. et al. The unfolded-protein-response sensor IRE-1alpha regulates the function of CD8alpha + dendritic cells. Nature immunology 15, 248-257, doi: 10.1038/ni.2808 (2014).
54. Messiaen, A. S., Nelis, H. & Coenye, T. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 13, 56-62, doi: 10.1016/j. jcf.2013.07.004 (2014).
55. Breyne, K. et al. Non-classical proIL-1beta activation during mammary gland infection is pathogen-dependent but caspase-1 independent. PloS one 9, e105680, doi: 10.1371/journal.pone.0105680 (2014).
56. Breyne, K., De Vliegher, S., De Visscher, A., Piepers, S. & Meyer, E. Technical note: A pilot study using a mouse mastitis model to study differences between bovine associated coagulase-negative staphylococci. Journal of dairy science 98, 1090-1100, doi: 10.3168/jds.2014-8699 (2015).